DelMar Pharmaceuticals announces closing of $10 million rdgistered direct offering
DelMar Pharmaceuticals announced it has closed on its previously announced registered direct offering, priced at-the-market. DelMar sold an aggregate of 8,000,000 shares of common stock and warrants at an offering price of $1.25 per share for gross proceeds of $10 million. September 22, 2017